Adeline Petit is an expert in Radiotherapy at Institut Bergonié (France). Adeline Petit has authored 54 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 152 (community average: 125). How the SLR is computed.

LeadR Profile

Adeline Petit Institut Bergonié France
152 ScienceLeadR Reputation 152
Network Map

Radiotherapy

Subspecialties: Oncology - Nuclear Medicine - Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 54

Citations

Citations: 297 1st author: 5 Last author: 1 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Adenoid cystic carcinoma of the breast: a case series of 26 patients.
PMID 42283891 — genes, myb, genes, carcinoma, adenoid cystic, breast neoplasms, neoplasms, breast, therapeutics, adenoids, prognosis
Breast Cancer Res Treat20260
Corrigendum to 'Radiotherapy and brachytherapy for cervical cancer : Recommendations of the Société française de radiothérapie oncologique' [Cancer Radiother 29 (2025) 104753].
PMID 42013680 — radiotherapy, uterine cervical neoplasms, brachytherapy, neoplasms
Cancer Radiother20260
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.
PMID 41794436 — radiotherapy, breast neoplasms, neoplasms, breast, morbidity
Lancet Top journal20260
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E.
PMID 41345599 — radiotherapy, breast neoplasms, fibrosis, pain, neoplasms, aged, breast, therapeutics
BMC Cancer20250
Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HyptoG-01 phase 3 trial.
PMID 41173355 — radiotherapy, breast, beds, therapeutics, medical oncology
Radiother Oncol20253

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3
Phase 2 3

By status:

Active not recruiting 2
Completed 1
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A MULTICENTER SEEKING SIGNAL RANDOMISED OPEN LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS
2024-514032-25-00 — uterine cervical neoplasms, neoplasms, nivolumab
Phase 2Active not recruiting2024

LeadR Networks

Main global connection map